{"id":238727,"date":"2024-07-01T15:42:36","date_gmt":"2024-07-01T13:42:36","guid":{"rendered":"https:\/\/fefac.cat\/empresarial\/?p=238727"},"modified":"2024-07-01T15:42:46","modified_gmt":"2024-07-01T13:42:46","slug":"arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/","title":{"rendered":"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se"},"content":{"rendered":"\n

Antoni Torres, president de la FEFAC, recorda a RAC 1 els riscos d’adquirir f\u00e0rmacs online com aquest, que requereix recepta<\/strong><\/h2>\n\n\n\n

El sector farmac\u00e8utic est\u00e0 pendent avui del nou f\u00e0rmac per tractar l’obesitat i la diabetis tipus 2<\/strong>, que competir\u00e0 amb l’Ozempic<\/strong>. Aquest nou medicament, anomenat Mounjaro<\/strong>, t\u00e9 un cost de 270 \u20ac al mes<\/strong>, ja que de moment no \u00e9s finan\u00e7at per la seguretat social.<\/strong><\/p>\n\n\n\n

La farmac\u00e8utica <\/strong>que el comercialitza, la nord-americana Lilly<\/strong>, assegura que Mounjaro t\u00e9 la capacitat per satisfer una alta demanda del producte<\/strong> i evitar els problemes de subministrament<\/strong> que ha patit l’Ozempic.<\/p>\n\n\n\n

Ahir diumenge, el programa Via Lliure de RAC1, <\/strong>va convidar el president de la FEFAC<\/strong>, Antoni Torres<\/strong>, a parlar sobre aquest f\u00e0rmac. Mounjaro nom\u00e9s es podr\u00e0 adquirir amb recepta m\u00e8dica<\/strong>, per la qual cosa els farmac\u00e8utics adverteixen del perill de comprar aquest producte fora del circuit oficial<\/strong>. En aquest sentit, Torres, ha alertat sobre el risc de comprar f\u00e0rmacs per internet<\/strong>, especialment aquells que requereixen recepta m\u00e8dica. Torres ha subratllat que la soluci\u00f3 \u00e9s molt senzilla: “comprar a les farm\u00e0cies, on es garanteixen tots els circuits de seguretat”.<\/p>\n\n\n\n

“Hi ha molta gent que compra per internet medicaments i, fent aix\u00f2, est\u00e0 posant en risc la seva vida”, ha assegurat Torres. “Tampoc tens cap garantia que aquest medicament faci l’efecte<\/strong> que ha de fer. Nom\u00e9s s\u2019ha de comprar medicaments a trav\u00e9s del canal oficial, que \u00e9s la farm\u00e0cia”, ha recordat.<\/p>\n\n\n\n

La majoria de compres de medicaments per internet, a m\u00e9s, es fan per vies il\u00b7legals <\/strong>i inclouen principalment f\u00e0rmacs per perdre pes, controlar el metabolisme, tranquil\u00b7litzants i medicaments hormonals<\/strong>. Per altra banda, els metges insisteixen que aquests tipus de f\u00e0rmacs nom\u00e9s s\u2019han de prescriure si hi ha un diagn\u00f2stic d\u2019obesitat previ.<\/strong><\/p>\n\n\n\n

Podeu escoltar el primer tall aqu\u00ed<\/a> (a partir del minut 48:27). Tamb\u00e9 s’ha parlat de Mounjaro a partir del minut 54:00.<\/p>\n\n\n\n

Imatge de Lilly<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

El sector farmac\u00e8utic est\u00e0 pendent avui del nou f\u00e0rmac per tractar l’obesitat i la diabetis tipus 2, que competir\u00e0 amb l’Ozempic. Aquest nou medicament, anomenat Mounjaro, t\u00e9 un cost de 270 \u20ac al mes, ja que de moment no \u00e9s finan\u00e7at per la seguretat social.<\/p>\n","protected":false},"author":5,"featured_media":238728,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"793","footnotes":""},"categories":[2066,2075,10,11,101],"tags":[85,711,797,1154,1500,2489,2715,2899],"class_list":["post-238727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-recull-de-premsa","category-empresarials","category-fefac","category-sanitaria","tag-fefac","tag-farmaceutics","tag-diabetis","tag-obesitat","tag-antoni-torres","tag-rac1","tag-industria-farmaceutica-2","tag-mounjaro"],"yoast_head":"\nArriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se - FEFAC<\/title>\n<meta name=\"description\" content=\"La farmac\u00e8utica que el comercialitza, Lilly, assegura que Mounjaro evitar\u00e0 els problemes de subministrament.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se - FEFAC\" \/>\n<meta property=\"og:description\" content=\"La farmac\u00e8utica que el comercialitza, Lilly, assegura que Mounjaro evitar\u00e0 els problemes de subministrament.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-01T13:42:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-01T13:42:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/07\/Mounjaro_Kwikpen_image-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"90\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"lgallardo@fefac.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lgallardo@fefac.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/\"},\"author\":{\"name\":\"lgallardo@fefac.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\"},\"headline\":\"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se\",\"datePublished\":\"2024-07-01T13:42:36+00:00\",\"dateModified\":\"2024-07-01T13:42:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/\"},\"wordCount\":346,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Mounjaro_Kwikpen_image-1.png\",\"keywords\":[\"FEFAC\",\"farmac\u00e8utics\",\"diabetis\",\"obesitat\",\"Antoni Torres\",\"Rac1\",\"ind\u00fastria farmac\u00e8utica\",\"Mounjaro\"],\"articleSection\":[\"Actualitat\",\"Recull de premsa\",\"Empresarials\",\"FEFAC\",\"Sanit\u00e0ria\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/\",\"name\":\"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Mounjaro_Kwikpen_image-1.png\",\"datePublished\":\"2024-07-01T13:42:36+00:00\",\"dateModified\":\"2024-07-01T13:42:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\"},\"description\":\"La farmac\u00e8utica que el comercialitza, Lilly, assegura que Mounjaro evitar\u00e0 els problemes de subministrament.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Mounjaro_Kwikpen_image-1.png\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Mounjaro_Kwikpen_image-1.png\",\"width\":599,\"height\":90},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/1fd062d4deaeeca8c3e2fce65b312ce9\",\"name\":\"lgallardo@fefac.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/lucia-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se - FEFAC","description":"La farmac\u00e8utica que el comercialitza, Lilly, assegura que Mounjaro evitar\u00e0 els problemes de subministrament.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/","og_locale":"ca_ES","og_type":"article","og_title":"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se - FEFAC","og_description":"La farmac\u00e8utica que el comercialitza, Lilly, assegura que Mounjaro evitar\u00e0 els problemes de subministrament.","og_url":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/","og_site_name":"FEFAC","article_published_time":"2024-07-01T13:42:36+00:00","article_modified_time":"2024-07-01T13:42:46+00:00","og_image":[{"width":599,"height":90,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/07\/Mounjaro_Kwikpen_image-1.png","type":"image\/png"}],"author":"lgallardo@fefac.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lgallardo@fefac.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/"},"author":{"name":"lgallardo@fefac.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9"},"headline":"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se","datePublished":"2024-07-01T13:42:36+00:00","dateModified":"2024-07-01T13:42:46+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/"},"wordCount":346,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/07\/Mounjaro_Kwikpen_image-1.png","keywords":["FEFAC","farmac\u00e8utics","diabetis","obesitat","Antoni Torres","Rac1","ind\u00fastria farmac\u00e8utica","Mounjaro"],"articleSection":["Actualitat","Recull de premsa","Empresarials","FEFAC","Sanit\u00e0ria"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/","url":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/","name":"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/07\/Mounjaro_Kwikpen_image-1.png","datePublished":"2024-07-01T13:42:36+00:00","dateModified":"2024-07-01T13:42:46+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9"},"description":"La farmac\u00e8utica que el comercialitza, Lilly, assegura que Mounjaro evitar\u00e0 els problemes de subministrament.","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/07\/Mounjaro_Kwikpen_image-1.png","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2024\/07\/Mounjaro_Kwikpen_image-1.png","width":599,"height":90},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/arriba-a-les-farmacies-mounjaro-un-nou-medicament-per-aprimar-se\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Arriba a les farm\u00e0cies Mounjaro, un nou medicament per aprimar-se"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d'Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/1fd062d4deaeeca8c3e2fce65b312ce9","name":"lgallardo@fefac.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/lucia-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/238727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=238727"}],"version-history":[{"count":9,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/238727\/revisions"}],"predecessor-version":[{"id":238738,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/238727\/revisions\/238738"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/238728"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=238727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=238727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=238727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}